Spanish Registry of Esophagogastric Cancer
Launched by FUNDACIÓN SOCIEDAD ESPAÑOLA DE ONCOLOGIA MÉDICA · Jul 1, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Spanish Registry of Esophagogastric Cancer is a clinical trial designed to create a comprehensive online database that collects important information about patients with esophageal and stomach cancer. The goal of this study is to better understand these types of cancer, which can help improve how doctors manage and treat patients. By gathering and analyzing this data, researchers hope to enhance the quality of scientific studies and allow for comparisons with other cancer patient groups.
To participate in this trial, you must be an adult aged 18 or older who has been diagnosed with cancer of the esophagus or stomach. You should have been under medical care for at least three months, although patients who passed away early for any reason will not be included. If you join the study, you can expect to provide some clinical information about your health, which will help researchers learn more about cancer treatment and outcomes. This study is currently recruiting participants, and all genders are welcome to take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown).
- • Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause.
- Exclusion Criteria:
- • A patient for whom, for whatever reason, the information necessary to complete the database cannot be known or obtained.
About Fundación Sociedad Española De Oncologia Médica
The Fundación Sociedad Española de Oncología Médica (SEOM) is a prominent Spanish organization dedicated to advancing the field of medical oncology through research, education, and advocacy. Committed to improving cancer care, SEOM sponsors innovative clinical trials aimed at enhancing treatment options and patient outcomes. By fostering collaboration among healthcare professionals, researchers, and institutions, the foundation strives to promote evidence-based practices and disseminate knowledge that drives progress in oncology. SEOM's initiatives are pivotal in shaping the future of cancer treatment in Spain and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Barcelona, , Spain
Madrid, , Spain
Murcia, , Spain
Barcelona, , Spain
Madrid, , Spain
Alicante, , Spain
Valencia, , Spain
Madrid, , Spain
Barcelona, , Spain
Madrid, , Spain
Madrid, , Spain
Elche, Alicante, Spain
Elda, Alicante, Spain
Ciudad Real, , Spain
Sevilla, , Spain
Barcelona, , Spain
Palma De Mallorca, Islas Baleares, Spain
Logroño, La Rioja, Spain
Madrid, , Spain
Barcelona, , Spain
Córdoba, , Spain
Córdoba, Andalucía, Spain
Málaga, , Spain
Sevilla, Andalucia, Spain
Santa Cruz De Tenerife, , Spain
A Coruña, La Coruña, Spain
Alcorcón, Madrid, Spain
Oviedo, Asturias, Spain
Cartagena, Murcia, Spain
L'hospitalet De Llobregat, Barcelona, Spain
San Cristóbal De La Laguna, Santa Cruz De Tenerife, Spain
Ourense, , Spain
Pontevedra, , Spain
Sabadell, Barcelona, Spain
Salamanca, , Spain
Sevilla, Andalucía, Spain
Málaga, Andalucía, Spain
Palma De Mallorca, Islas Baleares, Spain
Galdakao, Vizcaya, Spain
Madrid, , Spain
Jaén, , Spain
Pamplona, , Spain
Santander, Cantabria, Spain
Murcia, Región De Murcia, Spain
A Coruña, , Spain
Patients applied
Trial Officials
Paula Dr Jiménez Fonseca, MD-PhD
Principal Investigator
Sociedad Española de Oncología Medica (SEOM)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials